Eli Lilly launches Zepbound KwikPen on Ro

Seeking Alpha - Thu, 04/02/2026 - 12:38

Does cooling AI data centers pay off? This auto supplier is up 1300% in five years

Seeking Alpha - Thu, 04/02/2026 - 12:36

Most vs. least shorted large-cap REITs at March end

Seeking Alpha - Thu, 04/02/2026 - 12:35

Nonfarm payrolls expected to rebound in March, unemployment rate may hold steady

Seeking Alpha - Thu, 04/02/2026 - 12:34

Most and least shorted financial stocks with up to $2B market cap at the end of March

Seeking Alpha - Thu, 04/02/2026 - 12:34

March-end snapshot: Most and least shorted REITs up to $2B market cap

Seeking Alpha - Thu, 04/02/2026 - 12:34

Most and least shorted large-cap financial stocks at the end of March

Seeking Alpha - Thu, 04/02/2026 - 12:34

SRLN: 7.7% Yield Remains Attractive, But Rate Cut Expectations Reduce Allocation Case

Seeking Alpha - Thu, 04/02/2026 - 12:32

Regeneron gains approval of every 20 week dosing for Eylea HD

Seeking Alpha - Thu, 04/02/2026 - 12:27

Benefits of Migrating Your Business to the Cloud in 2026

TalkMarkets - Thu, 04/02/2026 - 12:25
Benefits of Migrating Your Business to the Cloud in 2026

Maine governor backs millionaire tax as Senate primary tightens

Seeking Alpha - Thu, 04/02/2026 - 12:24

Duolingo Will Be Back On Track: Buy The Stock

Seeking Alpha - Thu, 04/02/2026 - 12:24

Atlas Lithium's Neves project tapped for potential funding under U.S.-Japan partnership

Seeking Alpha - Thu, 04/02/2026 - 12:21

We’re not seeing AI productivity gains yet – Apollo Global Management’s Torsten Slok

Seeking Alpha - Thu, 04/02/2026 - 12:20

BNDI: Defend Against Volatility With This Bond ETF

Seeking Alpha - Thu, 04/02/2026 - 12:18

Cogent Biosciences: Blockbuster Potential, Premium Valuation, Still A 'Buy'

Seeking Alpha - Thu, 04/02/2026 - 12:16

Price war among Canadian telecoms fueling a "race to the "bottom"—TD Cowen

Seeking Alpha - Thu, 04/02/2026 - 12:15

Lindsay sees MENA project deliveries continuing through Q3 and Q4, while galvanizing facility targets early 2027 startup

Seeking Alpha - Thu, 04/02/2026 - 12:13

Viridian Therapeutics, Inc. (VRDN) Discusses Positive Topline Results from Elegrobart REVEAL-1 Phase III Trial in Active Thyroid Eye Disease - Slideshow

Seeking Alpha - Thu, 04/02/2026 - 12:12

Tilray rebounds as Roth Capital upgrades to Buy after Q3 results

Seeking Alpha - Thu, 04/02/2026 - 12:08

Pages